Skip to main content
KTTA logo

Pasithea Therapeutics Corp.

KTTANASDAQHealthcareBiotechnology

$0.39Today:- (-)1Y −39.01%

As of Oct 28, 2026 close

Market cap
$12.62M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.28$2.06
Volume (live)
-
Avg. volume (3M)
256.92K

Pasithea Therapeutics (KTTA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Pasithea Therapeutics used $15.21M of cash in operating activities. Free cash flow was −$15.21M.

Pasithea Therapeutics Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Pasithea Therapeutics Corp. (KTTA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-20.43-13.90-15.51-11.73-2.17-0.04
Depreciation & Amortization0.660.650.650.010.000.00
Deferred Income Tax0.000.000.000.00-2.330.00
Stock Based Compensation0.300.770.590.841.220.00
Change in Working Capital-0.32-1.521.570.850.110.00
Change in Accounts Payable0.00-1.430.000.750.440.00
Change in Other Working Capital-0.32-0.091.570.10-0.330.00
Other Operating Activities4.570.08-0.73-1.85-1.580.00
Net Cash from Operating Activities-15.21-13.92-13.43-13.69-3.17-0.04
Investing Activities
Capital Expenditures0.000.00-0.03-0.11-0.020.00
Acquisitions0.000.000.00-2.190.000.00
Other Investing Activities0.010.000.32-0.630.000.00
Net Cash from Investing Activities0.010.000.40-2.93-0.020.00
Financing Activities
Debt Repayment0.000.00-0.390.000.000.00
Common Stock Issued63.974.520.000.0057.240.28
Common Stock Repurchased0.000.00-3.73-3.210.000.00
Other Financing Activities-0.454.520.00-3.21-1.310.00
Net Cash from Financing Activities63.524.52-3.73-3.2155.930.28
Summary
Effect of Forex Changes on Cash0.020.000.000.01-0.010.00
Net Change in Cash48.34-9.41-16.76-19.8152.720.24
Cash at Beginning of Period6.9216.3333.0952.970.240.00
Cash at End of Period55.266.9216.3333.0952.970.24
Free Cash Flow-15.21-13.92-13.46-13.80-3.20-0.04

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pasithea Therapeutics Cash Flow

What is Pasithea Therapeutics's free cash flow?

Pasithea Therapeutics had negative free cash flow of $15.21M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Pasithea Therapeutics pay dividends or buy back shares?

Pasithea Therapeutics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition